Increased expression of PD-L1: In reaction to the immune attack, tumor cells might adapt by upregulating their expression of PD-L1, which can overcome the blockage offered by anti-PD-1/PD-L1 antibodies [79,80]. This evidence concerns the gene PDCD1 and neoplasm.